Patients’ expectations of autologous hematopoietic stem cell transplantation as a treatment for MS

ConclusionMany MS patients are considering aHSCT as a treatment option, although they think that they are not well-informed regarding aHSCT. They prefer their neurologist as a source of information. Therefore, neurologists should pro-actively inform their patients about the potential benefits and risks of aHSCT to enable them to choose the best treatment option.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research